Position in ALEC
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$818,951
+$609,124 QoQ
Shares Held
380,908
+183.2% QoQ
Ownership
0.343%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 93%
Shared 0%
None 7%
Common Shares in ALEC Over Time
Shares Held
Position Value (USD)
Derivatives in ALEC
reported options exposure · as of Dec 31, 2024CallValue
$7,938
CallShares
4,200
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026BANK OF AMERICA CORP /DE/ holds $8,555,077,811 across 347 Biotechnology names. ALEC ranks #217 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,878,183 | $1,285,223,834 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,189,584 | $919,120,177 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
966,912 | $319,922,169 | |
| 4 | ARGX |
Argenx SE
|
400,117 | $292,185,437 | |
| 5 | INSM |
INSMED Inc
|
1,502,281 | $245,652,986 | |
| 6 | CYTK |
Cytokinetics Inc
|
3,125,436 | $205,997,485 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
1,014,800 | $191,847,936 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
2,913,109 | $188,274,232 |
All Filings in ALEC
Export CSV
32 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $818,951 | 380,908 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $209,827 | 134,506 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $728,996 | 246,283 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $481,471 | 343,909 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $415,716 | 337,982 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $7,938 | 4,200 | Call | Defined | 2025-02-14 | |
| 2024-12-31 | $602,243 | 318,648 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $1,691,113 | 362,900 | Shares | Defined | 2024-11-14 | |
| 2024-09-30 | $19,572 | 4,200 | Call | Defined | 2024-11-14 | |
| 2024-06-30 | $1,631,607 | 359,385 | Shares | Defined | 2024-08-14 | |
| 2024-06-30 | $19,068 | 4,200 | Call | Defined | 2024-08-14 | |
| 2024-03-31 | $2,128,978 | 353,651 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $3,513,713 | 440,315 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $2,751,490 | 424,613 | Shares | Defined | 2023-11-14 | |
| 2023-09-30 | $2,592 | 400 | Call | Defined | 2023-11-14 | |
| 2023-06-30 | $2,134,539 | 355,165 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $2,920,768 | 471,853 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $3,916,473 | 424,320 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $3,484,494 | 368,340 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,016 | 100 | Call | Defined | 2022-08-12 | |
| 2022-06-30 | $2,336,565 | 229,977 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $4,740,289 | 332,652 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $8,487,313 | 411,008 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $6,141,932 | 269,147 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $2,661,552 | 127,775 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $2,522,673 | 125,257 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $1,373,303 | 90,767 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $1,217,676 | 115,584 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $58,656 | 2,400 | Call | Defined | 2020-08-14 | |
| 2020-06-30 | $58,656 | 2,400 | Put | Defined | 2020-08-14 | |
| 2020-06-30 | $746,444 | 30,542 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $352,826 | 14,622 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||